Dr. Mayer holds a Ph.D. in Developmental, Regenerative, and Stem Cell Biology from Washington University in St. Louis. Her doctoral work focused on metabolic and cardiovascular disease, including mechanistic studies of novel therapeutic signaling pathways in preclinical animal models. At Nuventra Allyson will be contributing to clinical pharmacology studies and managing project deliverables and milestones for clients.
Education